SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001618835-18-000105
Filing Date
2018-11-07
Accepted
2018-11-07 06:36:54
Documents
70
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evfm-930201810xq.htm 10-Q 1060916
2 EXHIBIT 31.1 evfm-9302018ex311.htm EX-31.1 21654
3 EXHIBIT 31.2 evfm-9302018ex312.htm EX-31.2 21892
4 EXHIBIT 32.1 evfm-9302018ex321.htm EX-32.1 13247
  Complete submission text file 0001618835-18-000105.txt   6532979

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT evfm-20180930.xml EX-101.INS 1133679
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20180930.xsd EX-101.SCH 55959
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evfm-20180930_cal.xml EX-101.CAL 75694
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20180930_def.xml EX-101.DEF 400229
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20180930_lab.xml EX-101.LAB 694882
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20180930_pre.xml EX-101.PRE 482898
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36754 | Film No.: 181164632
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1